The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes.
about
Insights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismMicroRNA in Metabolic Re-Programming and Their Role in TumorigenesisInfluence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetesExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.MicroRNA Regulatory Networks as Biomarkers in Obesity: The Emerging Role.MicroRNAs in metabolism and metabolic disordersPostprandial regulation of hepatic microRNAs predicted to target the insulin pathway in rainbow trout.MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial functionMicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.Integrative analysis of porcine microRNAome during skeletal muscle development.miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.Retinoid X receptor α overexpression alleviates mitochondrial dysfunction-induced insulin resistance through transcriptional regulation of insulin receptor substrate 1The miRNA Transcriptome Directly Reflects the Physiological and Biochemical Differences between Red, White, and Intermediate Muscle Fiber Types.MicroRNA-21 Regulates PI3K/Akt/mTOR Signaling by Targeting TGFβI during Skeletal Muscle Development in PigsMiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.Control of mitochondrial activity by miRNAs.Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126.Depletion of mitochondrial DNA stabilizes C1qTNF-related protein 6 mRNA in muscle cells.MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 β Cells.Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.The miRNA Interactome in Metabolic HomeostasisAntidiabetic effects of pterosin A, a small-molecular-weight natural product, on diabetic mouse modelsmiRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression.miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes.Diminished skeletal muscle microRNA expression with aging is associated with attenuated muscle plasticity and inhibition of IGF-1 signaling.MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma.Downregulation of IRS-1 in adipose tissue of offspring of obese mice is programmed cell-autonomously through post-transcriptional mechanisms.A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue.Role of microRNAs in diabetes and its cardiovascular complications.The physiological and pathophysiological roles of adipocyte miRNAs.MicroRNAs in the onset and development of cardiovascular disease.MicroRNAs: the fine modulators of liver development and function.MicroRNA expression profiles differ between primary myofiber of lean and obese pig breeds.Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes.Biological roles of microRNAs in the control of insulin secretion and action.Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.
P2860
Q26739857-698A35F7-1B4D-4977-BCC9-78B3D57AAF07Q26746958-B1510516-B100-4850-BE96-B1761039382CQ26865641-C5BAADF6-97E7-47E6-9A48-E70B5748CD10Q28079163-2CE08AC5-A982-4DDE-ADDB-DC5FFEE588BBQ30387502-DD331054-FBAF-47D5-9E9A-DD7A3765BEF5Q30402389-3EEC8B74-5B25-4FA2-90E5-A45DF11E292EQ33612997-A5A76AE2-24EB-49EB-BF0E-D62ADDFE6EF7Q34305614-515BDC90-5AC7-43B5-B977-D789BAA2A350Q34431793-B1F9D0F0-F339-4597-8AC5-88B5FD3C854EQ34750679-698BAA90-006F-4FE2-B044-C28F326195FAQ34988387-D5E6E7CE-287C-444A-8D79-8CE1CEE4CF21Q35100268-D8BC7208-EF39-42A2-BD6B-F9D43FA81080Q35450836-9D166171-5511-4A24-939D-1F8E89DB7304Q35621803-5FA6E782-6ACC-4770-9AAC-DC79AF0EA67DQ35624059-7B073E5E-F3BC-42B9-A898-713401891F9AQ35625246-CD0204C6-831B-4F5E-A23F-F5825B127809Q35885951-5105BE29-2A71-4D5A-B26F-7BB1600D2456Q35911210-0CC1487A-4DD9-4DF6-9527-F587883D4345Q35928934-96A4507A-6B2D-43B8-BF1A-BA81872DD382Q35937550-A3AE3210-830D-4105-8E4A-0B13FEEBC011Q36312962-997415A0-0887-4E86-9BD2-F1C9C85764A3Q36355502-37E88A50-E992-4FDC-8E35-5ACAFEA86687Q36560620-E851C42A-D8E6-4A24-9B0A-14560156545FQ37015090-002F2240-6132-41A5-9D49-9FA5747E6A52Q37117127-3BCF7B58-A71D-4689-83DD-ECE1BC1311B7Q37311926-42CDB99C-08A8-4846-8A4F-354F23E2936AQ37326779-A5607C20-E030-4085-AEB3-023947C24BBFQ37392712-BB19480E-223B-4D84-AAA5-E91397BA3970Q37702581-C7E270AD-021E-46F4-A9AC-C41C16E30D56Q37719408-CD147E79-21E5-4C4A-B41A-BD0BCD1A0AF1Q37953896-537516C8-52C0-4594-B0B7-9DD16C3EB1F8Q38121902-84121F4B-A8ED-4EAA-A5B3-D51D08E12EFDQ38150359-F8638A9A-D4D0-433B-A01F-883A9EEAD9E6Q38187190-1E5C8AD5-D3D4-4909-9AE8-A8301FA26198Q38430533-EC8F63C4-B201-4639-B4B7-EC1666D38D80Q38537772-013FFCB7-0463-4E6A-B905-4F7A0E38C94EQ38993402-76A22496-4095-47E7-814C-8BBE3EB95999Q38999205-62B5A0CC-DECC-453D-A03E-F5470A9BD9E1Q39032370-7255F779-D856-48FB-A7E3-C2074448E66CQ39095744-3907D60D-F8E6-43EE-8BEF-F396BFF884C7
P2860
The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The induction of microRNA targ ...... al dysfunction in hepatocytes.
@ast
The induction of microRNA targ ...... al dysfunction in hepatocytes.
@en
type
label
The induction of microRNA targ ...... al dysfunction in hepatocytes.
@ast
The induction of microRNA targ ...... al dysfunction in hepatocytes.
@en
prefLabel
The induction of microRNA targ ...... al dysfunction in hepatocytes.
@ast
The induction of microRNA targ ...... al dysfunction in hepatocytes.
@en
P2093
P2860
P1433
P1476
The induction of microRNA targ ...... al dysfunction in hepatocytes.
@en
P2093
Hyun Su Ryu
Seung-Yoon Park
P2860
P304
P356
10.1371/JOURNAL.PONE.0017343
P407
P50
P577
2011-03-25T00:00:00Z